STEEDMAN ANDREW CLIFFORD enters CANNAPHARMARX, INC. with 4K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/4/2020ACC: 0001683168-20-000343
Officer· Chief Operating Officer
Since Apr 2019
4K
Baseline shares
100% direct
4K
Direct ownership
1 position
5M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Series A Convertible Preferred Stock
DirectShares owned4K
Total
4K direct4K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series A Convertible Preferred Stock | 4K | Direct |
| Total | 4K | 4K direct |
Derivative Holdings1
Series A Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
5M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
5M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock | — | — | 5M | N/A | |
| Total | 5M | 0.00 | ||||